Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SSAO inhibitor-2
Cat. No.:
OB0425LY-141
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
SSAO inhibitor-2 is a compound that inhibits the enzyme aldo-keto reductase (SSAO), which has been linked to a variety of pathologies, including diabetes and cardiovascular disease.
Synonyms:
2671028-06-9; 1-[5-[(E)-2-(Aminomethyl)-3-fluoroprop-2-enoxy]pyrimidin-2-yl]-4-methylpiperidin-4-ol
CAS No.:
2671028-06-9
Compound CID:
164516820
Formula:
C14H21FN4O2
Formula Weight:
296.34
Specification
Target:
Monoamine oxidase
Pathway:
Neuronal signaling
Storage:
Storage at -20°C.
Applications:
SSAO inhibitor-2 can be used in studies of atherosclerosis, diabetes mellitus, obesity,, chronic kidney disease, autoimmune diseases, and multiple sclerosis.
